Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
A single amyloidogenic protein is implicated in multiple neurological diseases and capable of generating a number of aggregate “strains” with distinct structures. Among the amyloidogenic proteins, α-synuclein generates multiple patterns of proteinopathies in a group of diseases, such as Parkinson disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). However, the link between specific conformations and distinct pathologies, the key concept of the strain hypothesis, remains elusive. Here we show that in the presence of bacterial endotoxin, lipopolysaccharide (LPS), α-synuclein generated a self-renewable, structurally distinct fibril strain that consistently induced specific patterns of synucleinopathies in mice. These results suggest that amyloid fibrils with self-renewable structures cause distinct types of proteinopathies despite the identical primary structure and that exposure to exogenous pathogens may contribute to the diversity of synucleinopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Chronic oral application of P. gingivalis or injection of P. gingivalis LPS results in brain inflammation and neurodegeneration in wild-type mice [70, 89].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [70]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, LPS induces the formation of a distinct type of α-syn fibrils, similar to the pattern of wild-type α-syn fibril induction commonly observed in individuals with PD.239”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [239]
Experimental — accuracy not yet measuredIn the citing paper
“injection of endotoxin into mice induces α-synuclein production and aggregation, as well as loss of dopaminergic neurons in the substantia nigra.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [70]
In the citing paper
“Endotoxin may also promote the production or aggregation of amyloid β [66–68], tau [68, 69] and α-synuclein [70, 71].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [70]
In the citing paper
“Endotoxin increases α-synuclein production by macrophages [100] and drives α-synuclein fibrillization [70, 71].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Heteronuclear decoupling in rotating solids
Bennett, A. E., Rienstra, C. M., Auger, M., Lakshmi, K. V., & Griffin, R. G. (1995) · The Journal of Chemical Physics · doi:10.1063/1.470372 · Cited by 2,124
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Ramped-Amplitude Cross Polarization in Magic-Angle-Spinning NMR
Metz, G., Wu, X. L., & Smith, S. O. (1994) · Journal of Magnetic Resonance, Series A · doi:10.1006/jmra.1994.1208 · Cited by 1,217
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,090
Self-citationA General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,057
– dipolar-assisted rotational resonance in magic-angle spinning NMR
Takegoshi, K., Nakamura, S., & Terao, T. (2001) · Chemical Physics Letters · doi:10.1016/s0009-2614(01)00791-6 · Cited by 1,012
Structural and functional characterization of two alpha-synuclein strains
Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., Madiona, K., Olieric, V., Böckmann, A., Meier, B. H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3575 · Cited by 909
Prion-like spreading of pathological α-synuclein in brain
Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M. A., & Hasegawa, M. (2013) · Brain · doi:10.1093/brain/awt037 · Cited by 867
Self-citation
Cited by
Items 101–138 of 138
Immunotherapies for Parkinson’s Disease: Progression of Clinical Development
Teng, J. S., Ooi, Y. Y., Chye, S. M., Ling, A. P. K., & Koh, R. Y. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210526160926 · Cited by 11
Yang, L., Fan, S., Sun, L., Han, J., Wang, M., & Yu, T. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1643305 · Cited by 12
“Studies have also shown that LPS can induce a structurally unique self-replicating α -Syn fibril strain in mice, which triggers a signature pattern of synucleinopathy similar to that induced by wild-type α -Syn commonly observed in PD (57).”
A Protofilament-Protofilament Interface in the Structure of Mouse α-Synuclein Fibrils
Lv, G., Kumar, A., Huang, Y. T., & Eliezer, D. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.05.011 · Cited by 9
Self-citationAn, D.-H., & Xu, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30175 · Cited by 10
Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease
Page, M. J., & Pretorius, E. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1733960 · Cited by 12
Altered Gut Microbial Load and Immune Activation in a Drosophila Model of Human Tauopathy
Rydbom, J., Kohl, H., Hyde, V. R., & Lohr, K. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.731602 · Cited by 10
Distinct cryo-EM Structure of α-synuclein Filaments derived by TauPreprint
Hojjatian, A., Dasari, A. K. R., Sengupta, U., Taylor, D. W., Daneshparvar, N., Yeganeh, F. A., Dillard, L. B., Michael, B. C., Griffin, R. G., Borgnia, M. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.31.424989 · Cited by 9
“Indeed, various co-factors that interact with the N- and/or C-terminal regions promoted the formation of fibrillar aggregates of αsynuclein.(50-52) Recently solved cryo-EM structures of ex vivo α-synuclein filaments extracted from MSA and DLB patients revealed that the ex vivo filaments adopt distinct molecular struct…”
BackgroundInfections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease
Shannon, K. M. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223271 · Cited by 11
“Preclinical evidence suggests that bacterial lipopolysaccharide may induce a distinct strain of AS fibrils that is self-renewable and drives a mouse model of PD [44].”
BackgroundThe intestinal luminal sources of α-synuclein: a gastroenterologist perspective
Lerner, A. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab024 · Cited by 9
Neto, J. R. M., Lima, V. D. A., & Follmer, C. (2023) · FEBS Journal · doi:10.1111/febs.17027 · Cited by 6
New Insights on the Role of Bioactive Food Derivatives in Neurodegeneration and Neuroprotection
Fisette, A., Sergi, D., Breton-Morin, A., Descôteaux, S., & Martinoli, M. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220919085742 · Cited by 6
Qamar, M. A., Tall, P., van Wamelen, D. J., Wan, Y.-M., Rukavina, K., Fieldwalker, A., Matthew, D., Leta, V., Bannister, K., & Chaudhuri, К. R. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.08.012 · Cited by 10
Olfactory Dysfunction as a Clinical Marker of Early Glymphatic Failure in Neurodegenerative Diseases
Sánchez‐Benavides, G., Iranzo, Á., Grau‐Rivera, O., Giraldo, D. M., & Buongiorno, M. (2025) · Diagnostics · doi:10.3390/diagnostics15060719 · Cited by 8
“Pathological α -synuclein has been detected in gastrointestinal tissues before motor symptoms appear [37], and gut dysbiosis may contribute to neuroinflammation and α -synuclein misfolding [38,39].”
Probiotic: A Gut Microbiota-Based Therapeutic Approaches for the Treatment of Parkinson’s Disease
Rout, M., Prusty, S. K., & Kar, D. M. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328332572241219102122 · Cited by 5
Intact cells selectively amplify and structurally remodel amyloid fibrilsPreprint
Ansari, S., Lagasca, D., Dumarieh, R., Xiao, Y., Krishna, S., Li, Y., & Frederick, K. K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.09.612142 · Cited by 6
Dynein‐Dependent Endo‐Lysosomal Degradation Drives Lewy Body Disorders Accompanied by Aβ Pathology
Zhou, L., Wang, Y., Liu, Y., Zhu, F., Gao, G., Li, C., Ai, P., Xu, J., Wang, J. J., Guo, L. Z., et al. (2025) · Advanced Science · doi:10.1002/advs.202414860 · Cited by 8
Lactobacillaceae and Parkinson's disease: An apparent paradox
van der Maden, M. M., Verbeek, M. M., & Beckers, M. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x241312401 · Cited by 10
Seneff, S., Nigh, G., & Kyriakopoulos, A. M. (2025) · Biocell · doi:10.32604/biocell.2025.066687 · Cited by 7
Parkinson’s disease beyond the brain: implications for treatments
Naeini, S. M., Lopez, M. D., Fraser, P. E., & Tandon, A. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1600782 · Cited by 4
Multimodal methods to study protein aggregation and fibrillation
Herrera, M. G., Giampà, M., Tonali, N., & Dodero, V. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90264-9.00006-4 · Cited by 7
Choi, T. S., Lee, J., Han, J. Y., Jung, B. C., Wongkongkathep, P., Loo, J. A., Lee, M. J., & Kim, H. I. (2018) · Angewandte Chemie · doi:10.1002/ange.201712286 · Cited by 4
Self-citationMendonça, I. P., da Silva, R. S., de Paiva, I. H. R., Costa, B. L. D. S. A., Teixeira, K. P. D. S. B., de Souza, J. R. B., & Peixoto, C. A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02152-2 · Cited by 6
“These fibrils have a greater capacity for propagation and aggregation, suggesting that inflammation induced by microbial agents may accelerate the deposition of aggregates in synucleinopathies (Kim et al. 2016 ; Sampson et al. 2016 ).”
Prion-Like Propagation in Neurodegenerative Diseases
Peelaerts, W., Baekelandt, V., & Brundin, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00008-0 · Cited by 4
Takeshige‐Amano, H., Igami, E., Okuzumi, A., Kamo, R., Iseki, M., Tsuyama, K., Wakamori, R., Okada, H., Taniguchi, D., Ueno, S., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-102851 · Cited by 2
Differential microglial responses to structurally distinct alpha-synuclein polymorphs
Chang, K., Kim, J., Iba, M., Park, J. H., Beilina, A., Syed, Z. A., Baena, V., Horan-Portelance, L., Cookson, M., You, S., et al. (2025) · Molecular Brain · doi:10.1186/s13041-025-01256-0 · Cited by 3
Self-citationAlpha-synuclein and neuroinflammation in Parkinson's disease
Varanita, T., & Bubacco, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00027-8 · Cited by 2
Conformational switch in the alpha-synuclein C-terminus domain directs its fibril polymorphsPreprint
Aguirre, C., Miyanoiri, Y., So, M., Tamaki, H., Maruno, T., Doi, J., Wang, N., Yamaguchi, K., Nakajima, K., Yamamori, Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.10.479831 · Cited by 2
Singh, S., Capacio, A., Braun, C. A., Carroll‐Portillo, A., Ryman, S. G., & Lin, H. C. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1672793 · Cited by 1
Breid, S., Bernis, M. E., Babila, J. T., Garza, M. C., Wille, H., & Tamgüney, G. (2017) · Journal of Visualized Experiments · doi:10.3791/55503 · Cited by 2
Immune response during idiopathic Parkinson's disease: From humans to animal models
Nissen, S. K., Ferreira, S. A., Klæstrup, I. H., & Romero‐Ramos, M. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.006 · Cited by 1
Joppe, K. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8016 · Cited by 1
Bacterial Endotoxins and Neurological Disorders: From Exposure to Therapeutic Interventions
Khan, Y. H., Liaqat, A., Mallhi, T. H., Abid, A., Alotaibi, N. H., & Khan, A. (2021) · Emerging contaminants and associated treatment technologies · doi:10.1007/978-3-030-66376-6_3
Depression in Parkinson’s Disease: A Trajectory Linking Gut Microbiota and Neuroinflammation
Kujur, P. P., Sahu, M. R., & Mondal, A. C. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_13 · Cited by 1
Vogel, V., Olari, L., Bauer, R., Burczyk, S., Witz, F., Walker, E., Jaber, N., Mauerer, S., Rupp, U., Stifel, U., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.31.635909
Etude physiopathologique de la diffusion de la maladie de parkinson au système nerveux autonome
Leclair‐Visonneau, L. (2017) · theses.fr (ABES) · doi:10.70675/6537e18cze1c8z4bd8zad04z73a63a9ae4fe
Fenyi, A. (2019) · theses.fr (ABES) · doi:10.70675/ca9a766cz5bd3z49d3z8d07z7df9d1133f88 · Cited by 1
“…nombreuses structures fibrillaires ou oligomériques, ayant différentes propriétés, ont été caractérisées (Näsström, 2011; Cremades et al., 2012; Bousset et al., 2013; Guo et al., 2013; Gath et al., 2014; Chen et al., 2015; Kim et al., 2016; Ma et al., 2016; Makky et al., 2016; Pieri et al., 2016).”
BackgroundInfluentialFlor, J., Izecksohn, D., Grasseschi, D., Junqueira, M., & Follmer, C. (2026) · Open Biology · doi:10.1098/rsob.260046
Xu, C., Li, W., Ma, X., Han, L., Cui, G., Zhao, J., Wang, X., & Guan, Y. (2026) · Cells · doi:10.3390/cells15181718
“Endotoxin has the potential to affect α ‑Syn conformation, with distinct LPS β ‑sheet struc‑ tures driving alterations in fibril density and corresponding behavioral phenotypes in an‑ imal models [129].”
Metadata
- Authors
- Kim, C., Lv, G., Lee, J. S., Jung, B. C., Masuda-Suzukake, M., Hong, C.-S., Valera, E., Lee, H.-J., Paik, S. R., Hasegawa, M., Masliah, E., Eliezer, D., & Lee, S.-J.
- Affiliations
- Seoul National University (KR)
- Weill Cornell Medicine (US)
- University of California San Diego (US)
- Konkuk University (KR)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Lee, Seung-Jae
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-08-04
- Volume
- 6
- Issue
- 1
- Pages
- 30891-30891
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4973277
- OpenAlex
- W2486618134
- Cited by
- 138
- References
- 44
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 6 · 2023: 14 · 2022: 22 · 2021: 29 · 2020: 16 · 2019: 15 · 2018: 15 · 2017: 6
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- National Research Foundation
- Fonds National de la Recherche Luxembourg
- National Institute on Aging (R37AG018440, R01AG018440, P50AG005131, R37AG019391, R01AG043384)
- National Institute of Neurological Disorders and Stroke (P30NS057096)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein, lipopolysaccharide, bacterial endotoxin, synucleinopathies, Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, protein aggregation, amyloid conformation, neurodegeneration
- MeSH terms
- Amyloid, Animals, Cells, Cultured, Female, Humans, Lipopolysaccharides, Mice, Inbred C57BL, Neurons, Parkinson Disease, Protein Structure, Tertiary, Microglia, Multiple System Atrophy, Lewy Body Disease, Protein Transport, Mice, alpha-Synuclein, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.